Search results
Author(s):
Sean DeAngelo
,
Badri Aryal
,
Maryam Haghshomar
,
et al
Added:
1 week ago
Author(s):
Narendra Singh
Added:
2 months ago
AHA 2025 — In this interview, Dr Narendra Singh (NSC Cardiology, Atlanta, US) reviews the latest AHA data on etripamil, an investigational intranasal, nondihydropyridine calcium channel blocker for the rapid self-termination of paroxysmal supraventricular tachycardia (PSVT).Dr Singh discusses the burden of PSVT, key findings from randomized and open-label studies, conversion rates with single and…
View more
Thomas Weber
Job title: Associate Professor
Author
Dan Burkhoff
Job title: Director
Author
José M de la Torre Hernández
Job title: Head of Hemodynamics and Interventional Cardiology
Author
Dimitrios Tziakas
Author
Ilaria Battistoni
Author
Jan-Malte Sinning
Job title: Interventional Cardiologist
Author
Added:
6 months ago
Source:
Radcliffe Cardiology
The long-term utility of beta-blockers following an uncomplicated myocardial infarction (MI) remains a subject of clinical debate. New secondary results from the AβYSS trial (Assessment of β-blocker interruption one Year after an uncomplicated myocardial infarction on Safety and Symptomatic cardiac events requiring hospitalization) reveal that interrupting this therapy leads to sustained…
View more
Joost Lumens
Research Area(s) / Expertise:
Job title: Full Professor of Computational Cardiology at Maastricht University
Author